Literature DB >> 6393400

Hormone receptors. An update and application.

C A Hubay, B Arafah, N H Gordon, S P Guyton, J P Crowe.   

Abstract

The introduction of measurements of hormone receptors in breast cancer tumor specimens provides a major advance in selection of patients likely to have hormone-dependent cancers. Endocrine adjuvant treatment for estrogen-positive breast cancers in both pre- and postmenopausal women has been shown to be effective in delaying recurrence. Whenever possible, estrogen and progesterone receptors should be measured in tumor tissue from all patients with breast cancer.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6393400     DOI: 10.1016/s0039-6109(16)43487-0

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  6 in total

1.  Eight-year follow-up of adjuvant therapy for stage II breast cancer.

Authors:  C A Hubay; N H Gordon; O H Pearson; J S Marshall; W L McGuire
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

Review 2.  Influence of sex hormones on pancreatic cancer.

Authors:  A Andrén-Sandberg; J Johansson
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

Review 3.  Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma.

Authors:  W E Fisher; P Muscarella; L G Boros; W J Schirmer
Journal:  Int J Pancreatol       Date:  1998-12

4.  Breast cancer prognosis in three different racial groups in relation to steroid hormone receptor status.

Authors:  R J Pegoraro; D Nirmul; S G Reinach; J P Jordaan; S M Joubert
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 5.  Androgen influence on exocrine pancreatic cancer.

Authors:  A Andrén-Sandberg
Journal:  Int J Pancreatol       Date:  1989-05

6.  Oestrogen and progesterone receptor distribution in the cancerous breast.

Authors:  C Panahy; J R Puddefoot; E Anderson; G P Vinson; C L Berry; M J Turner; C L Brown; A W Goode
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.